Denver, Colorado - Momentum is building across small-cap names this week, with a mix of technical breakouts, clinical validation, and commercialization milestones driving a more constructive tone beneath the surface of the market.
Leading the charge is Lunai Bioworks (NASDAQ:LNAI), which has emerged as the session’s standout momentum mover. After bouncing off its 52-week low, the stock has pushed through multiple resistance levels, setting up a classic squeeze dynamic. Traders are now watching premarket highs around $0.64 and support-turned-inflection near $0.48, as continued strength could force short covering and extend the move.
While LNAI is being driven by technicals, fundamentals are also taking center stage across the biotech space. bioAffinity Technologies (NASDAQ:BIAF) added to its growing body of clinical evidence with a new case study highlighting its CyPath Lung diagnostic. In the report, a high-risk patient with multiple lung nodules avoided an invasive biopsy after the test indicated a low likelihood of cancer, later confirmed by follow-up imaging. With prior clinical data showing 92% sensitivity and 88% accuracy in detecting lung cancer in small nodules, the company continues to build a real-world case for noninvasive diagnostics that could reduce costs and unnecessary procedures.
Elsewhere in biotech, ImmunityBio (NASDAQ:IBRX) gained a regulatory tailwind after updated NCCN guidelines expanded the use of its ANKTIVA therapy in combination with BCG to include additional bladder cancer patients. While not yet an FDA label expansion, guideline inclusion often plays a meaningful role in physician adoption and reimbursement pathways, signaling growing clinical acceptance.
Outside of healthcare, innovation stories are also gaining traction. Kraig Biocraft Laboratories (OTCQB:KBLB) is pushing toward commercial-scale production of spider silk using genetically engineered silkworms, deploying one million silkworm eggs across facilities in Vietnam. The company’s approach, combining ancient sericulture with modern gene editing, aims to finally unlock scalable production of a material long prized for its strength and elasticity, with early shipments to global partners already in motion.
In transportation and infrastructure, U Power Limited (NASDAQ:UCAR) marked a key commercialization milestone, completing production of its first 30 battery-swapping electric heavy trucks for deployment in Thailand. The pilot, part of a planned 1,000-vehicle rollout, will test a model designed to eliminate charging downtime, a major bottleneck in fleet electrification, while generating data to support broader global expansion.
Meanwhile, the physical AI and autonomy ecosystem continues to take shape. AEye (NASDAQ:LIDR) is deepening its alignment with NVIDIA’s safety and AI infrastructure while reporting growing commercial traction, including a 40% expansion in its pipeline and increasing customer adoption. The company’s positioning across automotive, defense, and smart infrastructure reflects broader investor interest in the long-term “physical AI” opportunity.
Rounding out the session, Jet.AI (NASDAQ:JTAI) announced a $5 million share repurchase program, signaling management confidence as it builds out GPU and AI cloud infrastructure, while flyExclusive (NYSE:FLYX) is leaning into high-margin aviation services with Starlink installations that could evolve into a standalone revenue stream.
For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit www.kraiglabs.com
About 24/7 Market News
In today's fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you're an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact sales@247marketnews.com to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 24/7 is a third-party media provider that owns KBLB shares, which are on deposit and may be sold at the editor’s discretion, and has been compensated for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions.
For further information, please visit 247marketnews.com or https://go.247marketnews.com/kblb-disclosure/
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.
